ID: ALA4175429

Max Phase: Preclinical

Molecular Formula: C10H14Cl2N2

Molecular Weight: 160.22

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCc1ccncc1C#CCN.Cl.Cl

Standard InChI:  InChI=1S/C10H12N2.2ClH/c1-2-9-5-7-12-8-10(9)4-3-6-11;;/h5,7-8H,2,6,11H2,1H3;2*1H

Standard InChI Key:  DRKANXYRBYFMJP-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 160.22

Molecular Weight (Monoisotopic): 160.1000

AlogP: 0.95

#Rotatable Bonds: 1

Polar Surface Area: 38.91

Molecular Species: BASE

HBA: 2

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 2

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 8.52

CX LogP: 1.31

CX LogD: 0.16

Aromatic Rings: 1

Heavy Atoms: 12

QED Weighted: 0.62

Np Likeness Score: -0.29

References

1. Denton TT, Srivastava P, Xia Z, Chen G, Watson CJW, Wynd A, Lazarus P..  (2018)  Identification of the 4-Position of 3-Alkynyl and 3-Heteroaromatic Substituted Pyridine Methanamines as a Key Modification Site Eliciting Increased Potency and Enhanced Selectivity for Cytochrome P-450 2A6 Inhibition.,  61  (16): [PMID:29995408] [10.1021/acs.jmedchem.8b00084]

Source

Source(1):

• Scientific Literature